Intoxication with Magnesium Sulfate in the Treatment of Eclampsia a Propos of Three Cases and Review of the Literature
Keywords:
magnesium sulfate; preeclampsia; eclampsia, intoxication, treatment
Abstract
Hypertensive diseases of pregnancy are among the first causes of severe maternal morbidity and mortality especially in developing countries. In developed countries, eclampsia is a rare event, but remains responsible for a significant maternal mortality. For over a century, magnesium sulfate is widely used in the United States in many obstetric indications including the treatment of eclampsia crises. There appears to be no consensus to treat or prevent seizures by magnesium sulfate. However, a large, multicentre, randomized trial compared the efficacy of magnesium sulfate with diazepam or phenytoin in eclamptic women. In this trial, magnesium sulfate was associated with a significantly lower rate of recurrent seizures and lower rate of maternal death than that observed with other anticonvulsants. The main objective of magnesium sulfate prophylaxis in women with preeclampsia is to prevent or reduce the rate of eclampsia and complications associated with eclampsia.
Downloads
- Article PDF
- TEI XML Kaleidoscope (download in zip)* (Beta by AI)
- Lens* NISO JATS XML (Beta by AI)
- HTML Kaleidoscope* (Beta by AI)
- DBK XML Kaleidoscope (download in zip)* (Beta by AI)
- LaTeX pdf Kaleidoscope* (Beta by AI)
- EPUB Kaleidoscope* (Beta by AI)
- MD Kaleidoscope* (Beta by AI)
- FO Kaleidoscope* (Beta by AI)
- BIB Kaleidoscope* (Beta by AI)
- LaTeX Kaleidoscope* (Beta by AI)
How to Cite
References
M. Belfort, J. Anthony, B. Kirshon (1991) Respiratory function in severe gestational proteinuric hypertension: the effects of rapid volume expansion and subsequent vasodilatation with verapamil. 98, 964-972.
Terrone DA, Rinehart BK, Kimmel ES, May WL, Larmon JE, Morrison JC (2000) A prospective, randomized, controlled trial of high and low maintenance doses of magnesium sulfate for acute tocolysis. 182, 1477-82.
Grimes DA, Nanda K (2006) Magnesium sulfate tocolysis: time to quit. 108, 9869.
D. Altman, G. Carroli, L. Duley, B. Farrell, J. Moodley, J. Neilson, D. Smith (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. 359, 1877-1890.
Baha Sibai (2005) Sibai BM. Diagnosis, prevention, and management of eclampsia. 105(2), 402-410. https://doi.org/10.1097/01.aog.0000152351.13671.99
Hupuczi P, Sziller I, Hruby E, Rigo B, Szabo G, Papp Z (2006) The rate of maternal complications in 107 pregnancies complicated with HELLP syndrome. 147, 1377-1385.
Sibai BM (2006) Preeclampsia As a Cause of Preterm and Late Preterm (Near-Term) Births. 30, 16-19.
M. Chan, R. Boet, S. Ng, W. Poon, T. Gin (2005) Magnesium sulfate for brain protection during temporary cerebral artery occlusion. 95, 107-111.
Sameshima H, Ota A, Ikenoue T (1999) Pretreatment with magnesium sulfate protects against hypoxic-ischemic brain injury but postasphyxial treatment worsens brain damage in seven-day-old rats. 180, 725-730.
Sibai BM (1990) Magnesium sulfate is the ideal anticonvulsant in prééclampsie-eclampsia. 162, 1141-1145.
J. Golding (1998) A randomised trial of low dose aspirin for primiparae in pregnancy The Jamaica low dose aspirin study group. 105, 293-299.
The eclampsia collaborative group (1995) Which anticonvulsant for women with eclampsia ?Evidence from the collaborative eclampsia trial.Lancet 1995. 345, 1455-1463.
Witlin AG, Friedman SA, Sibai BM (1997) The effect of magnesium sulfate therapy on the duration of labor in women with mild preeclampsia at term: A randomized, double-blind, placebo-controlled trial. 176, 623-627.
Belfort MA, Tooke-Miller C, Allen JC, Dizon- D, Varner MA (2002) LABETALOL DECREASES CEREBRAL PERFUSION PRESSURE WITHOUT NEGATIVELY AFFECTING CEREBRAL BLOOD FLOW IN HYPERTENSIVE GRAVIDAS. 21, 185-197.
A. Richards, L. Stather -Dunn, J. Moodley (1985) Richards A, Stather -Dunn L, Moodley J. Cardiopulmonary arrest after the administration of magnesium sulfate. 67, 145.
ACOG bulletin (2002) Diagnosis and management of preeclampsia and eclampsia. 99, 159-167.
P. Rozenberg (2006) Intérêt du sulfate de magnésium dans la prise en charge de la prééclampsie. 34, 54-59.
Duley L, Gulmezoglu AM, Henderson-Smart DJ (2003) Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. 25.
Idama TO, Lindow SW Magnesium sulphate: a review of clinical pharmacology applied to obstetrics. 105, 260-268.
(2009) Recommandations formalisées d'experts communes. 38, 351-357.
Sibai BM (2004) Magnesium sulfate prophylaxis in preeclampsia: lessons learned from recent trials. 190, 1520-1526.
B. Girard, G. Beucher, C. Muris, T. Simonet, M. Dreyfus (2005) Sulfate demagnésium et prééclampsies sévères : utilisation en pratique courante. 34, 17-22.
The Magpie Trial Collaborative Group (2002) Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. 359, 1877-1890.
E. Coetzee, J. Dommisse, J. Anthony (1998) A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre‐eclampsia. 105, 300-303.
Belfort MA, Anthony J, Saade GR, Allen JC (2003) A Comparison of Magnesium Sulfate and Nimodipine for the Prevention of Eclampsia. 348, 304-311.
Barrilleaux Isler CM, Magann Rinehart BK (2003) Postpartum seizure prophylaxis: Using maternal clinical parameters toguide therapy. 101, 66-69.
Published
2014-02-07
Issue
Section
License
Copyright (c) 2014 Authors and Global Journals Private Limited
This work is licensed under a Creative Commons Attribution 4.0 International License.